Compare GOSS & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOSS | VREX |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.7M | 580.6M |
| IPO Year | 2019 | N/A |
| Metric | GOSS | VREX |
|---|---|---|
| Price | $2.32 | $13.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $8.83 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 5.5M | 424.6K |
| Earning Date | 03-12-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $44,051,000.00 | ★ $854,400,000.00 |
| Revenue This Year | N/A | $4.78 |
| Revenue Next Year | $6.41 | $4.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.09 |
| 52 Week Low | $0.76 | $6.76 |
| 52 Week High | $3.87 | $14.57 |
| Indicator | GOSS | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 39.85 | 49.28 |
| Support Level | $2.24 | $12.00 |
| Resistance Level | $2.41 | $14.39 |
| Average True Range (ATR) | 0.22 | 0.62 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 21.85 | 61.29 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.